Skip to main navigation Skip to search Skip to main content

Synthesis and structure-activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles

  • Ben Ren Liao
  • , Hai Bing He
  • , Ling Ling Yang
  • , Li Xin Gao
  • , Liang Chang
  • , Jie Tang
  • , Jing Ya Li*
  • , Jia Li
  • , Fan Yang
  • *Corresponding author for this work
  • East China Normal University
  • Nantong University
  • CAS - Shanghai Institute of Materia Medica

Research output: Contribution to journalArticlepeer-review

Abstract

With the aim of discovering a novel class of non-phosphorus-based fructose-1,6-bisphosphatase (FBPase) inhibitors, a series of 2,5-diphenyl-1,3,4-oxadiazoles were synthesized based on the hit compound (1) resulting from a high-throughput screening (HTS). Structure-activity relationship (SAR) studies led to the identification of several compounds with comparable inhibitory activities to AMP, the natural allosteric inhibitor of FBPase. Notably, compound 22 and 27b, bearing a terminal carboxyl or 1H-tetrazole, demonstrated remarkable inhibition to gluconeogenesis (GNG). In addition, both inhibition and binding mode to the enzyme were investigated by enzymatic kinetics and in silico experiments for representative compounds 16 and 22.

Original languageEnglish
Pages (from-to)15-25
Number of pages11
JournalEuropean Journal of Medicinal Chemistry
Volume83
DOIs
StatePublished - 18 Aug 2014

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

  1. SDG 3 - Good Health and Well-being
    SDG 3 Good Health and Well-being

Keywords

  • 2,5-Diphenyl-1,3,4-oxadiazoles
  • Antidiabetic
  • Diabetes
  • Fructose-1,6-bisphosphatase (FBPase)
  • Inhibitor

Fingerprint

Dive into the research topics of 'Synthesis and structure-activity relationship of non-phosphorus-based fructose-1,6-bisphosphatase inhibitors: 2,5-Diphenyl-1,3,4-oxadiazoles'. Together they form a unique fingerprint.

Cite this